In advanced non-small cell lung cancer, a potential correlation between CRP elevation and poorer cancer response to ICI therapy, in addition to the correlation between an early decline in CRP and better response to ICI therapy, has been demonstrated 6. The gene discussed is CRP; the disease is non-small cell lung carcinoma.